Universities and colleges
Disruption of Angiogenesis and Tumor Growth with New Orally Active Drug
Researchers have published a report in the Proceedings of the National Academy of Sciences of the United States of America detailing the discovery of a new drug that stabilizes the inactive state of PDGFRbeta/B-RAF, leading to disruption of angiogenesis and tumor growth. This breakthrough in cancer research has significant